Cosmos Health Inc. has authorized a share repurchase program of up to $5 million of its outstanding common stock. The program will run for six months, ending on December 31, 2026, unless extended. Repurchases will be conducted through open market purchases, privately-negotiated transactions, or block purchases, in compliance with federal securities laws, including Rule 10b-18. The company may also enter into written trading plans under Rule 10b5-1 to facilitate repurchases during blackout periods. The CEO stated the program reflects confidence in operating fundamentals and growth prospects, citing record revenue, improving margins, and global expansion. The repurchase amount represents nearly half of the company's market capitalization as of June 29, 2026. The company believes repurchasing shares at current levels is an attractive opportunity to enhance shareholder value.